Arrakis is a company focused on extending small-molecule medicines into new realms of biology by discovering small-molecule compounds that act directly on RNA. They are pioneering new territory with a team of skilled scientists and drug development leaders who are inventive yet pragmatic. Their mission is to impact millions of patients by targeting RNA biology in new ways and reaching hundreds of biological targets not currently accessible to medicine. Their goal is to develop powerful new therapies for patients everywhere by opening up a new path for discovering RNA-targeted medicines.